Lymphangioma medical therapy: Difference between revisions
Jump to navigation
Jump to search
Badria Munir (talk | contribs) No edit summary |
Badria Munir (talk | contribs) No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{HL}} | {{CMG}} {{AE}} {{HL}} | ||
==Overview== | ==Overview== | ||
* There is no medical treatment for lymphangioma; the mainstay of therapy is surgery. | * There is no particular medical treatment for lymphangioma; the mainstay of therapy is surgery. | ||
==Medical Therapy== | ==Medical Therapy== | ||
| Line 9: | Line 9: | ||
* However propranolol is a potential option, which can be used in intractable lymphangiomatosis.<ref name="pmid1533">{{cite journal |vauthors=Sack M, Cassidy JT, Bole GG, Vinar O |title=Prognostic factors in polyarteritis |journal=J. Rheumatol. |volume=2 |issue=4 |pages=411–20 |date=December 1975 |pmid=1533 |doi= |url=}}</ref> | * However propranolol is a potential option, which can be used in intractable lymphangiomatosis.<ref name="pmid1533">{{cite journal |vauthors=Sack M, Cassidy JT, Bole GG, Vinar O |title=Prognostic factors in polyarteritis |journal=J. Rheumatol. |volume=2 |issue=4 |pages=411–20 |date=December 1975 |pmid=1533 |doi= |url=}}</ref> | ||
* Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.<ref name="pmid1524">{{cite journal |vauthors=Moos F, Richard P, Sugiura M, Iwasaki K, Kato R |title=[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)] |language=French |journal=J. Physiol. (Paris) |volume=70 |issue=3 |pages=315–32 |date=November 1975 |pmid=1524 |doi= |url=}}</ref> | * Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.<ref name="pmid1524">{{cite journal |vauthors=Moos F, Richard P, Sugiura M, Iwasaki K, Kato R |title=[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)] |language=French |journal=J. Physiol. (Paris) |volume=70 |issue=3 |pages=315–32 |date=November 1975 |pmid=1524 |doi= |url=}}</ref> | ||
Other Therapies | |||
*Destructive treatments with carbon dioxide (CO2) laser | |||
*long-pulsed Nd-YAG laser | |||
electrosurgery | |||
Cryotherapy | |||
superficial radiotherapy | |||
sclerotherapy with 23.4% hypertonic saline | |||
Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol | |||
==References== | ==References== | ||
Revision as of 23:11, 16 October 2018
|
Lymphangioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphangioma medical therapy On the Web |
|
American Roentgen Ray Society Images of Lymphangioma medical therapy |
|
Risk calculators and risk factors for Lymphangioma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
- There is no particular medical treatment for lymphangioma; the mainstay of therapy is surgery.
Medical Therapy
There is no medical treatment for lymphangioma; the mainstay of therapy is surgery.
- However propranolol is a potential option, which can be used in intractable lymphangiomatosis.[1]
- Sodium tetradecyl sulfate is an off lable option for treatment of lymphangioma circumscriptum.[2]
Other Therapies
- Destructive treatments with carbon dioxide (CO2) laser
- long-pulsed Nd-YAG laser
electrosurgery
Cryotherapy
superficial radiotherapy sclerotherapy with 23.4% hypertonic saline
Direct injection of a sclerosing agent, including 1% or 3% sodium tetradecyl sulfate, doxycycline or ethanol
References
- ↑ Sack M, Cassidy JT, Bole GG, Vinar O (December 1975). "Prognostic factors in polyarteritis". J. Rheumatol. 2 (4): 411–20. PMID 1533.
- ↑ Moos F, Richard P, Sugiura M, Iwasaki K, Kato R (November 1975). "[Adrenergic and cholinergic control of oxytocin release evoked by vaginal, vagal and mammary stimulation in lactating rats (author's transl)]". J. Physiol. (Paris) (in French). 70 (3): 315–32. PMID 1524.